Efficacy and safety in a 4-year follow-up of the ELEVATE-TN study comparing acalabrutinib with or without obinutuzumab versus obinutuzumab plus chlorambucil in treatment-naïve chronic lymphocytic leukemia.
作者信息
Sharman Jeff P, Egyed Miklos, Jurczak Wojciech, Skarbnik Alan, Pagel John M, Flinn Ian W, Kamdar Manali, Munir Talha, Walewska Renata, Corbett Gillian, Fogliatto Laura Maria, Herishanu Yair, Banerji Versha, Coutre Steven, Follows George, Walker Patricia, Karlsson Karin, Ghia Paolo, Janssens Ann, Cymbalista Florence, Woyach Jennifer A, Ferrant Emmanuelle, Wierda William G, Munugalavadla Veerendra, Yu Ting, Wang Min Hui, Byrd John C
机构信息
Willamette Valley Cancer Institute and Research Center, Eugene, OR, USA.
Somogy County Mór Kaposi General Hospital, Kaposvár, Hungary.
出版信息
Leukemia. 2022 Apr;36(4):1171-1175. doi: 10.1038/s41375-021-01485-x. Epub 2022 Jan 1.
Abstract
摘要
Zotero 插件